|
|
|
Volumn 65, Issue 10, 2016, Pages S23-S28
|
|
An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Innovations in Insulin: Insulin Glargine U-300
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
BIOLOGICAL MARKER;
GLUCOSE BLOOD LEVEL;
GLYCOSYLATED HEMOGLOBIN;
INSULIN GLARGINE;
ADULT;
AGED;
ANALYSIS;
BLOOD;
BODY MASS;
BODY WEIGHT;
CASE REPORT;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADULT;
AGED;
BIOMARKERS;
BLOOD GLUCOSE;
BODY MASS INDEX;
BODY WEIGHT;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS, SUBCUTANEOUS;
INSULIN GLARGINE;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 85021857679
PISSN: None
EISSN: 15337294
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|